NULL
Kentucky

Expanding Applications of NX Prenatal’s Exosome-Based Diagnostics Platform Presented at Key Conferences

HOUSTON and LOUISVILLE, Ky., Nov. 13, 2018 /PRNewswire/ -- NX Prenatal Inc., a privately held women's healthcare molecular diagnostic company, announced today that expanding applications of its proprietary NeXosome® liquid biopsy platform…
Continue Reading »